VRAX — Virax Biolabs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapFalling Star

Annual balance sheet for Virax Biolabs, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	20-F	10-K	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.022	9.35	3.59	4.23	6.44
Net Total Accounts Receivable
Net Total Receivables	0	—	0.218	0.031	0.027
Total Inventory
Prepaid Expenses
Total Current Assets	0.049	9.63	4.38	4.89	6.83
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	1.1	1.53	1.5
Net Intangible Assets
Total Assets	0.049	9.81	5.48	6.43	8.32
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.25	0.908	0.169	0.673	0.685
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	1.02	0.686	0.117	0.731	0.747
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.975	9.13	5.37	5.7	7.58
Total Liabilities & Shareholders' Equity	0.049	9.81	5.48	6.43	8.32
Total Common Shares Outstanding